Page last updated: 2024-10-20

uracil and Common Bile Duct Neoplasms

uracil has been researched along with Common Bile Duct Neoplasms in 6 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Common Bile Duct Neoplasms: Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy."9.14A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009)
"The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy."5.14A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furuse, J1
Okusaka, T1
Ohkawa, S1
Nagase, M1
Funakoshi, A1
Boku, N1
Yamao, K1
Yamaguchi, T1
Sato, T2
Kitami, CE1
Kurosaki, I1
Koyama, Y1
Makino, H1
Hatakeyama, K1
Ishikawa, T1
Ishikawa, N2
Oota, H1
Yoshida, T1
Honma, A1
Kamimura, T1
Takeda, K1
Ozaki, T1
Iguchi, C1
Nio, Y1
Sato, Y1
Watanabe, H1
Ohishi, T1
Abe, M1
Yano, S1
Sumi, S1
Tamura, K1
Moreira, LF1
Iwagaki, H1
Hizuta, A1
Sakagami, K1
Mimura, H1
Orita, K1
Shibata, T1
Kondo, H1
Ootani, I1
Suzuki, H1
Kawada, S1

Trials

1 trial available for uracil and Common Bile Duct Neoplasms

ArticleYear
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Cancer chemotherapy and pharmacology, 2009, Volume: 65, Issue:1

    Topics: Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Du

2009

Other Studies

5 other studies available for uracil and Common Bile Duct Neoplasms

ArticleYear
Long-term survival after hepatectomy for hepatic recurrence of carcinoma of the papilla of Vater.
    Journal of hepato-biliary-pancreatic surgery, 2005, Volume: 12, Issue:4

    Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Ampulla of Vater; Antineoplastic Combined

2005
[A case of common bile duct cancer responding to MMC leucovorin, 5-FU, and UFT combination chemotherapy and radiation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Common Bile Duct Ne

1996
[A case of recurrent ampullary carcinoma of the papilla of Vater, in which a complete response was induced by combination therapy using radiotherapy and oral chemotherapy employing UFT and cyclophosphamide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:11

    Topics: Administration, Oral; Adult; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Combi

1999
Can cytokines prolong survival in ampullary neuroendocrine carcinomas?
    The American journal of gastroenterology, 1992, Volume: 87, Issue:12

    Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Thera

1992
[Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:12

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chole

1990